 Estradiol
"Estradiol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
| Descriptor ID |
D004958
|
| MeSH Number(s) |
D04.210.500.365.415.248 D06.472.334.851.437.500
|
| Concept/Terms |
Estradiol- Estradiol
- Estradiol-17 beta
- Estradiol 17 beta
- Estradiol Anhydrous
- Oestradiol
- Estradiol-17beta
- Estradiol 17beta
- 17 beta-Estradiol
- 17 beta Estradiol
- 17 beta-Oestradiol
- 17 beta Oestradiol
|
Below are MeSH descriptors whose meaning is more general than "Estradiol".
Below are MeSH descriptors whose meaning is more specific than "Estradiol".
This graph shows the total number of publications written about "Estradiol" by people in this website by year, and whether "Estradiol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 2 | 5 | | 1997 | 2 | 3 | 5 | | 1998 | 2 | 4 | 6 | | 1999 | 0 | 2 | 2 | | 2000 | 4 | 4 | 8 | | 2001 | 4 | 4 | 8 | | 2002 | 6 | 4 | 10 | | 2003 | 9 | 4 | 13 | | 2004 | 2 | 2 | 4 | | 2005 | 6 | 5 | 11 | | 2006 | 6 | 7 | 13 | | 2007 | 9 | 8 | 17 | | 2008 | 8 | 10 | 18 | | 2009 | 5 | 8 | 13 | | 2010 | 10 | 5 | 15 | | 2011 | 5 | 8 | 13 | | 2012 | 6 | 9 | 15 | | 2013 | 8 | 7 | 15 | | 2014 | 5 | 7 | 12 | | 2015 | 9 | 7 | 16 | | 2016 | 7 | 4 | 11 | | 2017 | 6 | 9 | 15 | | 2018 | 6 | 7 | 13 | | 2019 | 6 | 5 | 11 | | 2020 | 6 | 6 | 12 | | 2021 | 5 | 5 | 10 | | 2022 | 0 | 7 | 7 | | 2023 | 2 | 10 | 12 | | 2024 | 4 | 2 | 6 | | 2025 | 9 | 4 | 13 | | 2026 | 3 | 3 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Estradiol" by people in Profiles.
-
Valenti WB, Ruzzene ST, Berry AR, Orozco-Fersiva NC, Stone MF, Gilmore EC, Holzer JP, Mollaian JS, Greiner JJ, Garcia VP, DeSouza CA. Effect of 17ß-estradiol on brain microvascular endothelial cell oxidative stress, apoptotic susceptibility, and fibrinolytic capacity. J Appl Physiol (1985). 2026 Jun 01; 140(6):1804-1812.
-
Moon RA, Sobrano Fais R, Kim M, Vogel NT, Mendelson JB, Hartweck LM, Carney JP, Gardner MK, Prins SE, Prisco SZ, Lahm T, Prins KW. 17ß-Estradiol counteracts pathological microtubule remodeling to enhance right ventricular function in preclinical models. J Clin Invest. 2026 Jul 01; 136(13).
-
van Eeghen SA, Pyle L, Narongkiatikhun P, Choi YJ, Vosters TG, van Valkengoed IGM, Bjornstad P, Siegelaar SE, Nokoff NJ, den Heijer M, van Raalte DH. Insulin Sensitivity and Associated Plasma Proteomics During Sex Hormone Therapy. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):e1070-e1079.
-
Shao C, Indeglia A, Foster M, Casey K, Leung J, Modarai SR, Leu JI, Duong B, Mes-Masson AM, Sims-Mourtada J, Auslander N, Drapkin R, Bitler BG, Zhang N, Murphy ME. Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer. Genes Dev. 2026 02 02; 40(3-4):199-214.
-
James TT, Dowling NM, Ferrer Simó C, Salazar H, Van Hulle CA, Ennis G, Johnson AL, Wyman MF, McLester-Davis LWY, Gooding DC, Fischer B, Bouges S, Umucu E, Kara F, Kling JM, Manson JE, Brinton EA, Cedars MI, Lobo RA, Neal-Perry G, Santoro NF, Naftolin F, Harman SM, Pal L, Miller VM, Kantarci K, Gleason CE. Association between central adiposity and cognitive domain function in recently postmenopausal women: an analysis from the KEEPS-Cog substudy of the Kronos Early Estrogen Preventive Study. Menopause. 2026 Feb 01; 33(2):151-160.
-
Kantarci K, Kara F, Tosakulwong N, Fought AJ, Schwarz CG, Senjem ML, Kendall-Thomas J, Min P, Lowe VJ, Jack CR, Kapoor E, Fields JA, Bailey KR, James TT, Faubion L, Lobo RA, Manson JE, Pal L, Hammers DB, Brinton EA, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE. Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial. Alzheimers Dement. 2026 Feb; 22(2):e71067.
-
Faubion LL, Mak E, Kara F, Tosakulwong N, Lesnick TG, Fought AJ, Reid RI, Schwarz CG, Kendall-Thomas J, Kapoor E, Fields JA, Bailey KR, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Brinton EA, Malek-Ahmadi M, Cedars M, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE, Kantarci K. Long-term effects of 4 years of menopausal hormone therapy on white matter integrity. Menopause. 2025 Sep 01; 32(9):818-828.
-
Misakian AL, Kelley CE, Sullivan EA, Chang JJ, Singh G, Kokosa S, Avila J, Cooper H, Liang JW, Botzheim B, Quint M, Jeevananthan A, Chi E, Harmer M, Hiatt L, Kowalewski M, Steinberg B, Tausinga T, Tanner H, Ho TF, Mark B, Zenger B, Hu S, Gebregzabheir A, Penny JM, Loeb DF, Strickland T, Iwamoto SJ, Rothman MS, Hamnvik OR, Ariel D. Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States. J Clin Endocrinol Metab. 2025 Aug 07; 110(9):e2898-e2907.
-
Misakian AL, Ariel D, Sullivan EA, Singh G, Loeb D, Strickland T, Iwamoto SJ, Rothman MS, Botzheim B, Liang JW, Kelley C, Hamnvik OR. Injectable Estradiol Monotherapy Effectively Suppresses Testosterone in Gender-Affirming Hormone Therapy. Endocr Pract. 2025 Nov; 31(11):1462-1469.
-
Richey RE, Miner JA, Miner JC, Brunt VE, Kaplan PF, Halliwill JR, Minson CT. Exogenous estradiol increases cardiovagal baroreflex sensitivity during a hypertensive stimulus in premenopausal young women. Am J Physiol Heart Circ Physiol. 2025 08 01; 329(2):H439-H449.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|